Most Australians want the maximum price of PBS medicines capped at $25 or less, according to new polling released by the ...
A group of students from across Australia spent two days in Canberra finding out how many doors a career in health can open.
The NDIS can fund an assistance dog's food, vet bills and grooming year after year. Meanwhile, women with breast cancer that has spread to the brain are denied funded access, and children with Crohn's ...
The real story is that per capita spending on the program, accounting for inflation and population growth, remains where it ...
A small Melbourne company founded by two medical researchers has landed one of Australia's biggest potential licensing deals.
Melbourne biotech Magellan Stem Cells is 17 years old and about to begin a pivotal Phase 3 trial of its stem cell treatment ...
Net spending on the Pharmaceutical Benefits Scheme rose by about $1.5 billion in 2025-26 as rebates paid by medicine ...
The current agreement between the Commonwealth and the research-based pharmaceutical industry promised faster access to new medicines through reforms to health technology assessment. Four years on, ...
Services Australia processed almost 10 million fewer PBS services in 2025–26 than in the previous year. Services Australia's 2025–26 annual report reveals the agency processed 233.6 million PBS ...
Uh Oh, We've Lost That Page! We're sorry... You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
Dr Brian McNamee AO will retire from CSL's board in March next year, and Gordon Naylor, who has served as Interim CEO and Managing Director since February, will become the company's chair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results